Salivary cortisol responses to dexamethasone in adolescents with posttraumatic stress disorder

被引:36
作者
Lipschitz, DS
Rasmusson, AM
Yehuda, R
Wang, S
Anyan, W
Gueoguieva, R
Grilo, CM
Fehon, DC
Southwick, SM
机构
[1] Yale Univ, Sch Med, New Haven, CT 06520 USA
[2] Mt Sinai Sch Med, New York, NY 10029 USA
关键词
adolescents; posttraumatic stress disorder; low-dose dexamethasone suppression test;
D O I
10.1097/01.chi.0000084832.67701.0d
中图分类号
B844 [发展心理学(人类心理学)];
学科分类号
040202 ;
摘要
Objective: Previous studies of adults with posttraumatic stress disorder (PTSD) have found various abnormalities in the regulation of the hypothalamic-pituitary-adrenal axis, including enhanced suppression of cortisol following low-dose dexamethasone. The purpose of the present study was to investigate salivary cortisol responses to low-dose dexamethasone in adolescents with PTSD. Method: Forty-eight adolescents (20 with current PTSD, 9 trauma controls without PTSD, and 19 healthy nontraumatized controls) were enrolled in the study. On day 1, baseline saliva samples were obtained at 8 A.M. and 0.5 mg of dexamethasone was administered at 11 P.M. Cortisol and dexamethasone levels were assessed at 8 A.M. the following day. Results: Adolescents with current PTSD showed no difference in the suppression of salivary cortisol in response to low-dose (0.5 mg) dexamethasone compared to trauma controls without PTSD and nontraumatized controls. More severely affected PTSD subjects with co-occurring major depression showed higher pre- and post-dexamethasone salivary cortisol levels compared to controls. Conclusions: The present study did not find evidence for enhanced suppression of salivary cortisol at 8 A.M. following low-dose dexamethasone in multiply traumatized adolescents with PTSD. This result differs from findings in adults with PTSD. Further investigations of hypothalamic-pituitary-adrenal axis abnormalities in traumatized children and adolescents are needed.
引用
收藏
页码:1310 / 1317
页数:8
相关论文
共 35 条
[1]  
Altemus M, 1997, NEUROPSYCHOPHARMACOL, V17, P100
[2]  
*AM PHYSCH ASS, 1994, DIAGN STAT MAN MENT
[3]  
AMAYAJACKSON L, 2000, P 47 ANN M AM AC CHI, P64
[4]  
[Anonymous], 1987, Am J Psychiatry, V144, P1253
[5]   Modulation of glucocorticoid receptor gene expression by antidepressant drugs [J].
Barden, N .
PHARMACOPSYCHIATRY, 1996, 29 (01) :12-22
[6]  
BARON JA, 1995, J PHARMACOL EXP THER, V272, P151
[7]  
Beck A.T., 1987, BECK DEPRESSION INVE
[8]  
BERNSTEIN DP, 1998, CHILDHOOD TRUAMA QUE
[9]   THE DEXAMETHASONE SUPPRESSION TEST FOR MELANCHOLIA [J].
CARROLL, BJ .
BRITISH JOURNAL OF PSYCHIATRY, 1982, 140 (MAR) :292-304
[10]   THE DEXAMETHASONE SUPPRESSION TEST IN CHILDREN AND ADOLESCENTS - A REVIEW AND A CONTROLLED-STUDY [J].
DAHL, RE ;
KAUFMAN, J ;
RYAN, ND ;
PEREL, J ;
ALSHABBOUT, M ;
BIRMAHER, B ;
NELSON, B ;
PUIGANTICH, J .
BIOLOGICAL PSYCHIATRY, 1992, 32 (02) :109-126